DISTURBANCES IN GAMMA GLOBULIN SYNTHESIS AS "EXPERIMENTS OF NATURE"

E. Mead Johnson Award

¹ Pediatric Research Laboratories of the Variety Club Heart Hospital, University of Minnesota

The experiment of nature presented by patients with agammaglobulinemia is discussed and related to other syndromes associated with disturbance in gamma globulin metabolism.

Measurement of serum gamma globulin concentration by an immunologic method revealed minute amounts of gamma globulin to be present in the serum of each of the patients with agammaglobulinemia. Measurement of the survival time of intramuscularly injected gamma globulin indicated that in patients with agammaglobulinemia this protein has a half-life of approximately 30 days.

The immunologic handicap in patients with agammaglobulinemia is defined in terms of response to ubiquitous antigen, the presence of "natural antibodies" and the primary, secondary, and tertiary responses to bacterial antigens, heterologous blood group antigens and virus antigens. The clinical paradox posed by the apparently satisfactory resistance of patients with agammaglobulinemia to certain virus infections and the failure of their response to virus antigen is discussed. The capacity of patients with agammaglobulinemia to develop bacterial-type hypersensitivity is documented. This observation dissociates bacterial type hypersensitivity from the classical immune response which results in accumulation of antibody in the circulating blood.

The development of immediate-type sensitivity in patients with agammaglobulinemia after intradermal injection of serum from a patient known to be atopic is described. Serum complement, acute phase reactants and properdin are present in normal concentrations in the serums of patients with agammaglobulinemia. The acute phase responses to infection and intoxication are normal in patients with agammaglobulinemia. The persistence of immunologic paralysis after the administration of gamma globulin to patients with agammaglobulinemia is documented.

Skin reactions, febrile and toxic response of patients with agammaglobulinemia to gram-negative endotoxin do not differ from those of immunologically normal persons. Refractoriness to the toxic and pyrogenic effects of gram-negative endotoxin develops in patients with agammaglobulinemia just as in normal persons.

The normal function of the pituitary-adrenal system in patients with agammaglobulinemia is established.

Multiple hematologic disturbances observed in patients with agammaglobulinemia are described. These include transient neutropenia, cyclic neutropenia, persistent neutropenia, eosinopenia, lymphopenia, aregenerative anemia, benign proliferation of the hematopoietic reticulum and thymoma. Virtual absence of plasma cells from the hematopoietic tissues and inflammatory exudates of patients with agammaglobulinemia is described. Failure of plasma cell formation in response to antigenic stimulation is reported as a constant characteristic of the patient with agammaglobulinemia. That all the hematologic abnormalities in agammaglobulinemia have a common basis in a functional abnormality of the hematopoietic reticulum is proposed.

Successful homotransplantation of skin in the patient with agammaglobulinemia is described. Transplantation of skin from 4 patients with agammaglobulinemia to 4 immunologically normal children resulted in the expected homotransplantation failure.

Immunologic, biochemical and hematologic studies of a woman with agammaglobulinemia during pregnancy are briefly described.

Immunologic, biochemical, and hematologic investigations of a child born of a mother with agammaglobulinemia are mentioned.

This article has been cited by other articles:

				T. W. LeBien and T. F. Tedder B lymphocytes: how they develop and function Blood, September 1, 2008; 112(5): 1570 - 1580. [Abstract] [Full Text] [PDF]

				K. Pueschel, A. Tietz, M. Carsillo, M. Steward, and S. Niewiesk Measles Virus-Specific CD4 T-Cell Activity Does Not Correlate with Protection against Lung Infection or Viral Clearance J. Virol., August 15, 2007; 81(16): 8571 - 8578. [Abstract] [Full Text] [PDF]

				M. J. Zilliox, W. J. Moss, and D. E. Griffin Gene Expression Changes in Peripheral Blood Mononuclear Cells during Measles Virus Infection Clin. Vaccine Immunol., July 1, 2007; 14(7): 918 - 923. [Abstract] [Full Text] [PDF]

				S. R. Permar, D. E. Griffin, and N. L. Letvin Immune Containment and Consequences of Measles Virus Infection in Healthy and Immunocompromised Individuals Clin. Vaccine Immunol., April 1, 2006; 13(4): 437 - 443. [Full Text] [PDF]

				C.-H. Pan, A. Valsamakis, T. Colella, N. Nair, R. J. Adams, F. P. Polack, C. E. Greer, S. Perri, J. M. Polo, and D. E. Griffin Inaugural Article: Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles PNAS, August 16, 2005; 102(33): 11581 - 11588. [Abstract] [Full Text] [PDF]

				I. G. Ovsyannikova, N. Dhiman, R. M. Jacobson, R. A. Vierkant, and G. A. Poland Frequency of Measles Virus-Specific CD4+ and CD8+ T Cells in Subjects Seronegative or Highly Seropositive for Measles Vaccine Clin. Vaccine Immunol., May 1, 2003; 10(3): 411 - 416. [Abstract] [Full Text] [PDF]

				S. R. Permar, S. A. Klumpp, K. G. Mansfield, W.-K. Kim, D. A. Gorgone, M. A. Lifton, K. C. Williams, J. E. Schmitz, K. A. Reimann, M. K. Axthelm, et al. Role of CD8+ Lymphocytes in Control and Clearance of Measles Virus Infection of Rhesus Monkeys J. Virol., April 1, 2003; 77(7): 4396 - 4400. [Abstract] [Full Text] [PDF]

				P. H. Verardi, F. H. Aziz, S. Ahmad, L. A. Jones, B. Beyene, R. N. Ngotho, H. M. Wamwayi, M. G. Yesus, B. G. Egziabher, and T. D. Yilma Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins J. Virol., January 15, 2002; 76(2): 484 - 491. [Abstract] [Full Text] [PDF]

				R. M. Zinkernagel Maternal Antibodies, Childhood Infections, and Autoimmune Diseases N. Engl. J. Med., November 1, 2001; 345(18): 1331 - 1335. [Full Text] [PDF]

				P. P. Sanna and D. R. Burton Role of Antibodies in Controlling Viral Disease: Lessons from Experiments of Nature and Gene Knockouts J. Virol., November 1, 2000; 74(21): 9813 - 9817. [Full Text]

				J. Welter, J. Taylor, J. Tartaglia, E. Paoletti, and C. B. Stephensen Vaccination against Canine Distemper Virus Infection in Infant Ferrets with and without Maternal Antibody Protection, Using Recombinant Attenuated Poxvirus Vaccines J. Virol., July 15, 2000; 74(14): 6358 - 6367. [Abstract] [Full Text]

				B. Schlereth, P.-G. Germann,, V. ter Meulen, and S. Niewiesk DNA vaccination with both the haemagglutinin and fusion proteins but not the nucleocapsid protein protects against experimental measles virus infection J. Gen. Virol., May 1, 2000; 81(5): 1321 - 1325. [Abstract] [Full Text]

				H. A. Gans, Y. Maldonado, L. L. Yasukawa, J. Beeler, S. Audet, M. M. Rinki, R. DeHovitz, and A. M. Arvin IL-12, IFN-{gamma}, and T Cell Proliferation to Measles in Immunized Infants J. Immunol., May 1, 1999; 162(9): 5569 - 5575. [Abstract] [Full Text] [PDF]

				G. J. Fennelly, S. A. Khan, M. A. Abadi, T. F. Wild, and B. R. Bloom Mucosal DNA Vaccine Immunization Against Measles with a Highly Attenuated Shigella flexneri Vector J. Immunol., February 1, 1999; 162(3): 1603 - 1610. [Abstract] [Full Text] [PDF]

				H. G. Kupfer and R. F. Clark Bleeding Tendency of a Vascular Nature in Patients with Multiple Allergies and Hypogammaglobulinemia Angiology, July 1, 1962; 13(7): 303 - 309. [PDF]

	Home | My Pediatrics | Journal Information | Current Issue | Past Issues | Subscriptions & Services | Contact Us Click here for faster international access © 1956 American Academy of Pediatrics. All rights reserved.